Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: Intramuscular Hydroxyprogesterone Caproate and Placenta Previa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of intramuscular hydroxyprogesterone caproate for pregnancies at risk of preterm labor, including placenta previa, has completed. Sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyprogesterone caproate (hydroxyprogesterone caproate)

Snippet

Sponsor: Assiut University | Conditions: Preterm Labor | Phase 2 | Status: COMPLETED